The American College of Surgeons (ACS) Committee on Perioperative Care sponsored the following sessions at the 100th Annual Clinical Congress in San Francisco, CA, held October 26–30, 2014.
Monday, October 27
ME112: The Relationship and Role of the Surgeon in Designing and Implementing Accountable Care Organizations (ACO)
Facilitator: Stephen T. Bartlett, Baltimore, MD
NL04: I.S. Ravdin Lecture in the Basic and Surgical Sciences
The Human Lung: A Self-Renewing Organ
Lecturer: Piero Ansversa, MD, FAHA, CCNS, Boston, MA
Presiding Officer: Mary T. Hawn, Birmingham, AL
Sponsored by the I.S. Ravdin Surgical Society since 1964 to honor Dr. Ravdin by promoting knowledge in basic sciences with application to surgery.
Tuesday, October 28
PS205: Perioperative Patient Safety
Moderator: Juan A. Sanchez, Baltimore, MD
Co-Moderator: Amy L. Halverson, Chicago, IL
This session will provide an overview of patient safety topics relevant to surgeons within the framework of the National Patient Safety Goals. Topics will encompass high reliability principles and a human factors view of the perioperative environment. The presentations will also cover AHRQ’s Patient Safety Indicators related to preventing procedural harm as well as the health care policy and financing landscape related to patient safety under the Affordable Care Act.
Wednesday, October 29
PS333: Innovation and Invention in Surgery: From Concept to Market
Moderator: T. Forcht Dagi, Newton Centre, MA
Co-Moderator: Raphael Bueno, Boston, MA
This session will outline the process of developing, protecting, funding, and commercializing innovations and inventions in surgery, including clinical trials design, regulatory strategies, market sizing, and exit planning. The session is an adaptation of material taught in the Biomedical Entrepreneurship Program of the Harvard-MIT Program in Health Sciences and Technology at Harvard Business School. Learning objectives include recognition and formulation of market opportunities; developing business plans; obtaining funding; market sizing; intellectual property, regulatory and reimbursement strategies; prototyping; cost engineering; revenue models; clinical trials; management of conflicts of interest; company formation and governance, including boards and advisors; strategic industry partnerships; distribution models; and exit strategies.
PS334: High-Risk Perioperative Patient Populations: Avoiding Adverse
Moderator: William Chiu, Baltimore, MD
Co-Moderator: Douglas J.E. Schuerer, St Louis, MO
Several high-risk patient populations present unique challenges to the general surgeon and surgical intensivist. Understanding these specific conditions is critical for mitigating the potential risks of an adverse outcome. The specific high-risk populations to be discussed during this session are: the cirrhotic patient; the immune-compromised patient; those with bleeding dyscrasias; the elderly; the obese; those with limited pulmonary reserve; and the pregnant patient. Practical pitfalls and strategies for optimizing outcomes in these patients will be discussed.